As per the latest research report titled ‘Global Hexamethyldisilazane (HMDS) Market (Value, Volume) - Analysis By Application, By Type, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)’ available with MarketStudyReport, global hexamethyldisilazane market held a valuation of USD 202.32 million in 2020 and is anticipated to record a robust growth rate through 2026.

Escalating demand for semiconductor processing and increasing product usage as a pharmaceutical intermediary are the major factors fueling global hexamethyldisilazane (HMDS) market growth.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3958918/   

For the unversed, hexamethyldisilazane (HMDS) is an organosilicon compound that acts as a reagent to bases and is majorly utilized as a silylating agent in the manufacturing process of pharmaceutical drugs like ARVs (Sofosbuvir, Lamivudine, and Emtricitabine) as well as antibiotics such as Cefprozil and Cefadroxil.

In addition, the product is widely utilized across different application spectrums such as organic synthesis, semiconductors and surface treatment, which is impelling the industry share.

For the purpose of comprehension, worldwide hexamethyldisilazane (HMDS) industry is segregated based on type, application spectrum, and regional terrain.

Speaking of the application spectrum, the marketplace is comprised of pharmaceutical, rubber, semiconductor, and others. The pharmaceutical segment slated to generate significant demand in the coming years. HMDS is extensively utilized in the pharmaceutical sector as a functional group protective agent, activator, and catalyst in producing antibiotics, nucleoside drugs, and cardiovascular drugs.

Considering semiconductor application, the product finds immense application in the modification of white carbon black powder surface and in diatomaceous earth powder to enhance its reinforcement, hydrophobicity and tear resistant capabilities, which is further amplifying the scope of the industry. Also, HMDS aids in improving cycling and electrochemical performance dynamics of the lithium battery components.

From a regional frame of reference, North America dominates the global market in terms of renumeration scale. This development can be attributed to growing geriatric population, increasing prevalence of chronic cardiovascular diseases, a robust healthcare infrastructure, burgeoning popularity of implantable medical devices among masses, and the pervasiveness of major industry players in the region.

The competitive terrain of global hexamethyldisilazane (HMDS) marketplace is defined by key players including BRB International B.V., Chemcon Specialty Chemicals Ltd., Evonik Industries AG, Shin Etsu Chemical Co. Ltd., Wacker Chemie AG, and DuPont de Nemours Inc.